Proteomics Intl Labs Ltd has released a press release.
June 2020 Quarterly Activities Report and Appendix 4C
Filed with ASX ·
6ix hasn’t read this filing yet.
Proteomics International Laboratories Ltd. on 6ix
Story so far
Earlier from Proteomics International Laboratories
- PromarkerD Intellectual Property portfolio expands
- Appendix 3Y - Directors on-market purchase of shares
- Big pharma clinical study validates PromarkerD kidney test
- Updated Investor Presentation
- Proteomics International receives COVID-19 research grants
Later from Proteomics International Laboratories
- Partnership with QIMR Berghofer targets oesophageal cancer
- First distribution agreement for PromarkerD immunoassay
- Proteomics International raises $6m in successful Placement
- September 2020 Quarterly Activities Report and Appendix 4C
- Completion of Placement and Appendix 2A
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories